Ambrisentan Tablets and Morphine Extended-Release Capsules
Determining the interaction of Ambrisentan Tablets and Morphine Extended-Release Capsules and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: ambrisentan
Brand name: Letairis
Synonyms: Ambrisentan
Generic Name: morphine
Brand name: Arymo ER, Kadian, MorphaBond ER, MS Contin, Avinza, Duramorph PF, Infumorph, Mitigo, RMS, Roxanol
Synonyms: Morphine, Morphine (Systemic)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Ambrisentan Tablets-Morphine Immediate-Release Tablets and Capsules
- Ambrisentan Tablets-Morphine injection
- Ambrisentan Tablets-Morphine Injection PF
- Ambrisentan Tablets-Morphine Long-Acting Tablets
- Ambrisentan Tablets-Morphine Oral Concentrate (20 mg/mL)
- Ambrisentan Tablets-Morphine Oral Solution
- Morphine Extended-Release Capsules-Amcinonide
- Morphine Extended-Release Capsules-Amcinonide Cream and Ointment
- Morphine Extended-Release Capsules-Amcinonide Lotion
- Morphine Extended-Release Capsules-Amcinonide Ointment
- Morphine Extended-Release Capsules-Amcinonide topical
- Morphine Extended-Release Capsules-Amcinonide Topical application